Advertisement

Acne in Dark Skin

  • Christos C. Zouboulis
  • Emeka Okoro
  • Raj Kubba
Chapter

Abstract

Acne vulgaris is a chronic, inflammatory disease of the sebaceous follicle characterized by increased sebum secretion and formation of follicle-associated closed and open comedones, papules, pustules and nodules; pseudocysts and several types of scars are sequelae of the primary lesions [1]. Acne is a most common skin disease seen worldwide. However, its incidence and clinical presentation differ in various geographic areas and ethnicities. The disease is less commonly seen in populations with dark skin living in developing countries in Africa. In contrast, acne is on the top list of dermatoses seen in African Americans in the USA [2, 3], indicating that environmental factors may play a prominent role in the pathogenesis of the disease. Acne vulgaris in dark skin is frequently either mild comedonal or nodular, in contrast to the classical presentation of acne papulopustulosa in fair skin (Table 18.1). In addition, facial acneiform dermatoses are frequently seen in patients with dark skin in Africa and India, more often than acne vulgaris itself. On the other hand, it seems that metabolic abnormalities associated with acne are overrepresented in India. Overall, the disease has a significant impact on the quality of life of young individuals worldwide and requires medical assistance and continuing support.

References

  1. 1.
    Zouboulis CC. Acne as a chronic systemic disease. Clin Dermatol. 2014;32:389–96.CrossRefPubMedGoogle Scholar
  2. 2.
    Alexis AF. Acne vulgaris in skin of color: understanding nuances and optimizing treatment outcomes. J Drugs Dermatol. 2014;13:s61–5.PubMedGoogle Scholar
  3. 3.
    Davis SA, Narahari S, Feldman SR, et al. Top dermatologic conditions in patients of color: an analysis of nationally representative data. J Drugs Dermatol. 2012;11:466–73.PubMedGoogle Scholar
  4. 4.
    Zouboulis CC. Acne vulgaris. Hautarzt. 2014;65:733–50.CrossRefPubMedGoogle Scholar
  5. 5.
    Okoro OE, Sani H. Pattern of skin diseases at the dermatology clinic of Jos University Teaching Hospital, Jos Plateau state Nigeria. Jos J Med. 2014;8:15–21.Google Scholar
  6. 6.
    Ogunbiyi AO, Omigbodun Y, Owoaje E. Prevalence of skin disorders in school children in South-West Nigeria. Int J Adolesc Med Health. 2009;21:235–41.CrossRefPubMedGoogle Scholar
  7. 7.
    Yahaya H. Acne vulgaris in Nigerian adolescents—prevalence, severity, beliefs, perceptions, and practices. Int J Dermatol. 2009;48:489–505.Google Scholar
  8. 8.
    Okoro OE, Ogunbiyi AO, George AO. Prevalence and pattern of acne vulgaris among adolescents in Ibadan, south-west Nigeria. J Egypt Women Dermatol Soc. 2016;13:7–12.CrossRefGoogle Scholar
  9. 9.
    Hartshorne ST. Dermatological disorders in Johannesburg, South Africa. Clin Exp Dermatol. 2003;148:193–4.Google Scholar
  10. 10.
    Ogunbiyi AO, Daramola OOM, Alese OO. Prevalence of skin diseases in Ibadan Nigeria. Int J Dermatol. 2004;43:31–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Henshaw EB, Olasode OA, Ogedegbe EE, et al. Dermatologic conditions in teenage adolescents in Nigeria. Adolesc Health Med Ther. 2014;5:79–87.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Lynn DD, Umari T, Dunnick CA, et al. The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther. 2016;7:13–25.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Perkins A, Cheng C, Hillebrand G, et al. Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indians and African American women. J Eur Acad Dermatol Venereol. 2011;25:1054–60.CrossRefPubMedGoogle Scholar
  14. 14.
    Cordain L, Lindeberg S, Hurtado M, et al. Acne vulgaris: a disease of western civilization. Arch Dermatol. 2002;138:1584–90.CrossRefPubMedGoogle Scholar
  15. 15.
    Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol. 2004;22:360–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Zouboulis CC, Jourdan E, Picardo M. Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. J Eur Acad Dermatol Venereol. 2014;28:527–32.CrossRefPubMedGoogle Scholar
  17. 17.
    Gollnick H, Zouboulis CC. Not all acne is acne vulgaris. Dtsch Arztbl Int. 2014;111:301–12.Google Scholar
  18. 18.
    Moradi-Tuchayi S, Makrantonaki E, Ganceviciene R, et al. Acne vulgaris. Nature Rev Dis Primers. 2015;1:15029.CrossRefGoogle Scholar
  19. 19.
    Herane MI, Ando I. Acne in infancy and acne genetics. Dermatology. 2003;206:24–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol. 2009;129:2136–41.CrossRefPubMedGoogle Scholar
  21. 21.
    Zouboulis CC. Is acne vulgaris a genuine inflammatory disease? Dermatology. 2001;203:277–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Zouboulis CC, Seltmann H, Hiroi N, et al. Corticotropin releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci U S A. 2002;99:7148–53.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Ganceviciene R, Graziene V, Fimmel S, et al. Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol. 2009;160:345–52.CrossRefPubMedGoogle Scholar
  24. 24.
    Pappas A, Fantasia J, Chen T. Age and ethnic variations in sebaceous lipids. Dermatoendocrinology. 2013;5:319–24.CrossRefGoogle Scholar
  25. 25.
    Zouboulis CC, Eady A, Philpott M, et al. What is the pathogenesis of acne? Exp Dermatol. 2005;14:143–52.CrossRefPubMedGoogle Scholar
  26. 26.
    Zouboulis CC, Schagen S, Alestas T. The sebocyte culture: a model to study the pathophysiology of the sebaceous gland in sebostasis, seborrhoea and acne. Arch Dermatol Res. 2008;300:397–413.CrossRefPubMedGoogle Scholar
  27. 27.
    Cappel M, Mauger D, Thibutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol. 2005;141:333–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Vora S, Ovhal A, Jerajani H, et al. Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne. Br J Dermatol. 2008;159:990–1.CrossRefPubMedGoogle Scholar
  29. 29.
    Kubba R, Bajaj AK, Thappa DM, et al. Acne in India: guidelines for management—IAA consensus document. Ind J Dermatol Venereol Leprol. 2009;75:S1–62.CrossRefGoogle Scholar
  30. 30.
    Silverberg JI, Silverberg NB. Epidemiology and extracutaneous comorbidities of severe acne in adolescence: an U.S. population-based study. Br J Dermatol. 2014;170:1136–42.CrossRefPubMedGoogle Scholar
  31. 31.
    Davis EC, Callender VD. A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies. J Clin Aesthet Dermatol. 2010;3:24–38.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Kubba R. Acne in dark skin people. In: Schwartz RA, Micali G, editors. Acne. Gurgaon: Macmillan; 2013. p. 39–50.Google Scholar
  33. 33.
    Kubba R, Chatrath V. Acne expression and management in Indians. World Clin Dermatol. 2013;1:105–27.Google Scholar
  34. 34.
    Jacinto-Jamora S, Tamesis J, Katigbak MI. Pityrosporum folliculitis in the Philippines: diagnosis, prevalence and management. J Am Acad Dermatol. 1991;24:693–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Youn NH, Cha SH, Park S. Malassezia yeasts in acne vulgaris. Korean J Dermatol. 2002;40:1453–60.Google Scholar
  36. 36.
    Ju Q, Yiang K, Zouboulis CC, et al. Chloracne: from clinic to research. Dermatol Sin. 2012;30:2–6.CrossRefGoogle Scholar
  37. 37.
    Adler YD, Zouboulis CC, Geilen CC, et al. Eine seltene Variante des SAHA syndroms. Z Hautkr. 2001;76:327–8.Google Scholar
  38. 38.
    Orfanos CE, Adler YD, Zouboulis CC. The SAHA syndrome. Horm Res. 2000;54:251–8.PubMedGoogle Scholar
  39. 39.
    Sanke S, Chander R, Jain A, et al. A comparison of the hormone profile of the early androgenetic alopecia in men with the phenotypic equivalent of polycystic ovarian syndrome in women. JAMA Dermatol. 2016;152:986–91.CrossRefPubMedGoogle Scholar
  40. 40.
    Svetlana T, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab. 2004;89:2526–34.CrossRefGoogle Scholar
  41. 41.
    Globerman H, Carnieli E. Analysis of the insulin receptor gene tyrosine kinase domain in obese patients with hyperandrogenism, insulin resistance and acanthosis nigricans. Int J Obes Relat Metab Disord. 1998;22:349–53.CrossRefPubMedGoogle Scholar
  42. 42.
    Dunaif A, Finegood DT. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1996;81:942–7.PubMedGoogle Scholar
  43. 43.
    Rahman MA, De D, Handa S, et al. Association of insulin-like growth factor (IGF-1) gene polymorphisms with plasma levels of IGF-1 and acne severity. J Am Acad Dermatol. 2016;75:768–73.CrossRefGoogle Scholar
  44. 44.
    Honour JW. 17-Hydroxyprogesterone in children, adolescents and adults. Ann Clin Biochem. 2014;51:424–40.CrossRefPubMedGoogle Scholar
  45. 45.
    Plewig G, Kligman AM. Induction of acne by topical steroids. Arch Dermatol Forsch. 1973;247:29–52.CrossRefPubMedGoogle Scholar
  46. 46.
    Saraswat A, Lahiri K, Chatterjee M, et al. Topical corticosteroid abuse on the face: a prospective, multicentre study of dermatology outpatients. Ind J Dermatol Venereol Leprol. 2011;77:160–6.CrossRefGoogle Scholar
  47. 47.
    Goh CL, Abad-Casinthan F, Chow SK, et al. Evaluating acne-related post-inflammatory hyperpigmentation is a challenge even amongst experts. J Dermatol. 2014;41:1106–8.CrossRefPubMedGoogle Scholar
  48. 48.
    Hayashi N, Miyachi Y, Kawashima M. Prevalence of scars and “mini-scars”, and their impact on quality of life in Japanese patients with acne. J Dermatol. 2015;42:690–6.CrossRefPubMedGoogle Scholar
  49. 49.
    Nast A, Dréno B, Bettoli V, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26(suppl 1):1–29.Google Scholar
  50. 50.
    Taylor SC, Cook-Bolden F, Rahman Z, et al. Acne vulgaris in skin of color. J Am Acad Dermatol. 2002;46:S98–106.CrossRefPubMedGoogle Scholar
  51. 51.
    Sardana K, Gupta T, Kumar B, et al. Cross-sectional pilot study of antibiotic resistance in Propionibacterium acnes strains in Indian acne patients using 16S-RNA polymerase chain reaction: a comparison among treatment modalities including antibiotics, benzoyl peroxide, and isotretinoin. Ind J Dermatol. 2016;61:45–52.CrossRefGoogle Scholar
  52. 52.
    Zouboulis CC, Rabe T. Hormonelle Antiandrogene in der Aknetherapie. J Dtsch Dermatol Ges. 2010;8(suppl 1):S60–74.CrossRefPubMedGoogle Scholar
  53. 53.
    Ganceviciene R, Zouboulis C. Isotretinoin for acne vulgaris: state-of-the-art treatment for acne vulgaris. J Dtsch Dermatol Ges. 2010;8(suppl 1):S47–59.Google Scholar
  54. 54.
    Borghi A, Mantovani L, Minghetti S, et al. Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission. J Eur Acad Dermatol Venereol. 2011;25:1094–8.CrossRefPubMedGoogle Scholar
  55. 55.
    Dhaked DR, Meena RS, Maheshwari A, et al. A randomized comparative trial of two low-dose isotretinoin regimens in moderate to severe acne vulgaris. Ind Dermatol Online J. 2016;7:378–85.CrossRefGoogle Scholar
  56. 56.
    Walling HW, Messingham M, Myers LM, et al. Improvement of acanthosis nigricans on isotretinoin and metformin. J Drugs Dermatol. 2003;6:677–81.Google Scholar
  57. 57.
    Fabbrocini G, Izzo R, Faggiano A, et al. Low glycaemic diet and metformin therapy: a new approach in male subjects with acne resistant to common treatments. Clin Exp Dermatol. 2016;41:38–42.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Christos C. Zouboulis
    • 1
  • Emeka Okoro
    • 2
  • Raj Kubba
    • 3
  1. 1.Departments of Dermatology, Venereology, Allergology and ImmunologyDessau Medical Center, Brandenburg Medical School Theodor FontaneDessauGermany
  2. 2.Dermatology Unit, Department of MedicineFederal Medical CentreKeffiNigeria
  3. 3.Delhi Dermatology Group, Kubba ClinicNew DelhiIndia

Personalised recommendations